AAAAAA

   
Results: 1-3 |
Results: 3
MDL-29311, A PHENOLIC ANTIOXIDANT INTERFERES WITH THE INTERACTION OF APOC WITH VLDL - A POSSIBLE EXPLANATION FOR ITS TRIGLYCERIDE-LOWERING EFFECT
Authors: SHEETZ MJ
Citation: Mj. Sheetz, MDL-29311, A PHENOLIC ANTIOXIDANT INTERFERES WITH THE INTERACTION OF APOC WITH VLDL - A POSSIBLE EXPLANATION FOR ITS TRIGLYCERIDE-LOWERING EFFECT, Journal of lipid research, 36(12), 1995, pp. 2609-2621
MDL-29311, AN ANALOG OF PROBUCOL, DECREASES TRIGLYCERIDES IN RATS BY INCREASING HEPATIC-CLEARANCE OF VERY-LOW-DENSITY LIPOPROTEIN
Authors: SHEETZ MJ BARNHART RL JACKSON RL ROBINSON KM
Citation: Mj. Sheetz et al., MDL-29311, AN ANALOG OF PROBUCOL, DECREASES TRIGLYCERIDES IN RATS BY INCREASING HEPATIC-CLEARANCE OF VERY-LOW-DENSITY LIPOPROTEIN, Metabolism, clinical and experimental, 43(2), 1994, pp. 233-240
MDL-29311 - ANTIOXIDANT WITH MARKED LIPID-LOWERING AND GLUCOSE-LOWERING ACTIVITY IN DIABETIC RATS AND MICE
Authors: JOHNSON MB HEINEKE EW RHINEHART BL SHEETZ MJ BARNHART RL ROBINSON KM
Citation: Mb. Johnson et al., MDL-29311 - ANTIOXIDANT WITH MARKED LIPID-LOWERING AND GLUCOSE-LOWERING ACTIVITY IN DIABETIC RATS AND MICE, Diabetes, 42(8), 1993, pp. 1179-1186
Risultati: 1-3 |